IRIS
CLEMENTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.618
AS - Asia 7.448
NA - Nord America 5.189
SA - Sud America 1.909
AF - Africa 149
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 22.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.949
RU - Federazione Russa 4.577
SG - Singapore 2.705
CN - Cina 2.397
BR - Brasile 1.570
SE - Svezia 1.093
HK - Hong Kong 954
VN - Vietnam 726
IT - Italia 609
FR - Francia 390
DE - Germania 296
GB - Regno Unito 170
IN - India 157
FI - Finlandia 131
AR - Argentina 127
BD - Bangladesh 115
CA - Canada 115
MX - Messico 71
EC - Ecuador 64
ID - Indonesia 63
PL - Polonia 61
IQ - Iraq 59
ZA - Sudafrica 55
IE - Irlanda 52
AT - Austria 49
ES - Italia 49
NL - Olanda 42
TR - Turchia 42
JP - Giappone 40
CO - Colombia 36
UZ - Uzbekistan 34
PY - Paraguay 28
SA - Arabia Saudita 26
VE - Venezuela 26
MA - Marocco 24
PK - Pakistan 23
CL - Cile 22
PH - Filippine 22
UA - Ucraina 22
TN - Tunisia 18
LT - Lituania 16
PE - Perù 15
UY - Uruguay 15
JM - Giamaica 14
JO - Giordania 12
RO - Romania 12
AU - Australia 11
DZ - Algeria 11
EG - Egitto 11
AE - Emirati Arabi Uniti 9
KE - Kenya 9
BE - Belgio 8
NI - Nicaragua 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
MY - Malesia 6
NP - Nepal 6
BH - Bahrain 5
BO - Bolivia 5
CR - Costa Rica 5
GA - Gabon 5
HU - Ungheria 5
IL - Israele 5
IR - Iran 5
KZ - Kazakistan 5
MD - Moldavia 5
AL - Albania 4
BG - Bulgaria 4
GR - Grecia 4
HN - Honduras 4
LB - Libano 4
NZ - Nuova Zelanda 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
GE - Georgia 3
GT - Guatemala 3
KW - Kuwait 3
MU - Mauritius 3
PA - Panama 3
BN - Brunei Darussalam 2
BS - Bahamas 2
DK - Danimarca 2
HR - Croazia 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
Totale 22.313
Salva come PNG Salva come JPEG
Città #
Singapore 1.105
Moscow 986
Hong Kong 946
Dallas 882
San Jose 749
Ashburn 745
Shanghai 474
Hefei 385
Princeton 359
Lawrence 356
Lauterbourg 328
Ho Chi Minh City 301
Beijing 260
Milan 225
New York 215
Hanoi 152
São Paulo 142
Los Angeles 124
Helsinki 98
Munich 72
Nuremberg 68
Warsaw 59
Orem 56
Dublin 49
Chennai 47
Santa Clara 47
Rome 44
Denver 43
Rio de Janeiro 43
Seattle 42
Brasília 41
Montreal 40
Boardman 39
Pune 39
Johannesburg 37
London 37
Poplar 36
Tokyo 35
Stockholm 34
Belo Horizonte 33
Guangzhou 32
Tashkent 32
Atlanta 30
Boston 30
Bologna 29
Da Nang 29
Washington 28
Frankfurt am Main 27
Toronto 26
Porto Alegre 25
Turku 25
Brooklyn 24
Haiphong 23
Mexico City 23
Shenzhen 23
Brescia 22
Chicago 22
Quito 22
Guarulhos 21
Houston 21
Amsterdam 20
Ankara 20
Guayaquil 20
Vienna 20
Ancona 19
Biên Hòa 19
Hangzhou 19
Tianjin 19
Falkenstein 18
Manchester 18
Baghdad 17
Manaus 17
Salvador 17
Campinas 16
Council Bluffs 16
Phoenix 16
Cesano Boscone 15
Ribeirão Preto 15
San Francisco 14
The Dalles 14
Hải Dương 13
Ninh Bình 13
Thái Bình 13
Turin 13
Buenos Aires 12
Caxias do Sul 12
Curitiba 12
Jakarta 12
Joinville 12
Montevideo 12
Recife 12
Santo André 12
Sorocaba 12
Amman 11
Asunción 11
Columbus 11
Contagem 11
Dhaka 11
Florianópolis 11
Fortaleza 11
Totale 10.873
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 201
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 169
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 162
Biobanking for COVID-19 research 145
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 143
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 143
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 139
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 128
The interferon landscape along the respiratory tract impacts the severity of COVID-19 128
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 127
A Biologically-validated HCV E1E2 Heterodimer Structural Model 127
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 125
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 125
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 124
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 122
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 121
Laparoscopic right hemicolectomy: the SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective trial on 1225 cases comparing intra corporeal versus extra corporeal ileo-colic side-to-side anastomosis 121
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 120
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 118
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 118
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 117
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 117
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 115
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 114
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 113
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 111
2-Aminothiazolones as Anti-HIV Agents That Act as gp120-CD4 Inhibitors 110
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 109
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 107
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 106
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 105
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 103
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 102
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 102
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 101
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 101
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 101
A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection 100
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 99
A closer look at prion strains: Characterization and important implications 99
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 99
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 99
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 98
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 97
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 96
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 96
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 95
Characterization of GBV-C infection in HIV-1 infected patients 94
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 94
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 94
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 93
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 92
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 92
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 90
Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group) 89
Three-row versus two-row circular staplers for left-sided colorectal anastomosis: a propensity score-matched analysis of the iCral 2 and 3 prospective cohorts 89
A SINGLE-STEP DNA EXTRACTION PROCEDURE FOR THE DETECTION OF SERUM HEPATITIS-B VIRUS SEQUENCES BY THE POLYMERASE CHAIN-REACTION 89
A NOVEL PROCEDURE FOR QUANTITATIVE POLYMERASE CHAIN-REACTION BY COAMPLIFICATION OF COMPETITIVE TEMPLATES 89
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 88
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients 88
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 88
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 87
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 87
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis 87
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 86
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 86
Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen 86
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 85
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 84
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 83
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 82
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 81
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 81
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 80
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 80
Amotosalen Photochemical Inactivation of Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) in Human Platelet Concentrates 79
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 79
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 78
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 78
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 76
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 76
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 76
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. 75
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 75
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 74
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 74
HCV E2 core structures and mAbs: something is still missing 73
Coronaviridae and SARS-associated coronavirus strain HSR1 73
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum 72
Role and potential therapeutic use of antibodies against herpetic infections 70
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 70
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 69
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 69
Viral Respiratory Pathogens and Lung Injury 69
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 67
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 67
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 67
Re: Testicular Microbiome in Azoospermic Men - First Evidence of the Impact of an Altered Microenvironment 65
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 65
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 64
Totale 9.762
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022232 6 3 20 72 19 18 15 15 12 18 8 26
2022/20231.989 811 463 167 18 26 224 71 112 71 5 13 8
2023/2024936 21 44 151 95 68 228 22 79 5 41 45 137
2024/20254.713 607 80 49 131 126 406 619 451 911 618 314 401
2025/202614.519 1.118 1.229 1.224 2.142 1.033 417 1.339 1.050 3.980 695 288 4
Totale 22.654